New patent expiration for Allergan drug GELNIQUE 3%

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for GELNIQUE+3%25
Annual Drug Patent Expirations for GELNIQUE+3%25

Gelnique 3% is a drug marketed by Allergan and is included in one NDA. There is one patent protecting this drug.

Drug patent litigation for GELNIQUE 3%.

This drug has fifty-two patent family members in twenty countries.

The generic ingredient in GELNIQUE 3% is oxybutynin. Additional details are available on the oxybutynin profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top